Aquilent Overview
- Founded
-
1979

- Status
-
Acquired/Merged
- Employees
-
310

- Latest Deal Type
-
M&A
- Financing Rounds
-
5
Aquilent General Information
Description
Developer of web-based software for the federal government. The company offers web-content management services for the acquisition, management, storage, preservation and delivery of content within and across an organization.
Contact Information
Website
www.aquilent.com
Formerly Known As
Commerce One e-Government Solutions
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
IT Consulting and Outsourcing
Acquirer
Primary Office
- 1100 West Street
- Laurel, MD 20707
- United States
Aquilent Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Aquilent Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of web-based software for the federal government. The company offers web-content management services for the a
IT Consulting and Outsourcing
Laurel, MD
310
As of 2017
0000
0000-00-00
000000&0
Aquilent Competitors (30)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Tranway Technologies | Corporation | Bengaluru, India | 00 | 00000 | 00000000 | 00000 |
000 | Corporation | Washingtonville, NY | 000 | |||
00000 | Corporation | Dallas, TX | 000 | |||
0000 00000000 (000 | Corporate Backed or Acquired | Baerum, Norway | 00 | 000000&0 | ||
0000000 0000000000 | Private Equity-Backed | Bethesda, MD | 0000 | 00000 | 000000000 | 00000 |
Aquilent Patents
Aquilent Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20190040014-A1 | Solid forms of an s-nitrosoglutathione reductase inhibitor | Active | 10-Sep-2015 | 0000000000 | |
US-10399946-B2 | Solid forms of an s-nitrosoglutathione reductase inhibitor | Active | 10-Sep-2015 | 0000000000 | |
AU-2015224464-A1 | Novel substituted quinoline compounds as s-nitrosoglutathione reductase inhibitors | Active | 08-Oct-2010 | ||
AU-2015224464-B2 | Novel substituted quinoline compounds as s-nitrosoglutathione reductase inhibitors | Inactive | 08-Oct-2010 |
Aquilent Signals
Aquilent Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|